US Corporate Board Director Changes SEC Filings — September 14, 2026

14-09-2026

On September 8, 2026, TransparentBusiness, Inc. (Unicoin Inc.) announced the resignation of Deniece Ky, Principal Accounting Officer and Senior Financial Director, effective September 17, 2026, due to personal reasons. The company will pay $42,755.89 for accrued but unused PTO. No replacement has been announced, and no other financial or operational metrics were disclosed.

14-09-2026

State Street Corporation announced two executive leadership appointments effective September 14, 2026. Mostapha Tahiri, formerly Enterprise Chief Operating Officer, has been appointed President of State Street Alpha and will continue as Chairman of Asia Pacific. Ann Fogarty, formerly Investment Services Chief Operating Officer, has been appointed Enterprise Chief Operating Officer, succeeding Mr. Tahiri, with a target incentive compensation award of $5,650,000.

• · Ann Fogarty, age 60, had served as State Street’s Executive Vice President and Chief Operating Officer of Investment Services since July 2025.
• · From March 2022 to July 2025, she served as Executive Vice President and Head of Global Delivery.
• · Ms. Fogarty joined State Street in March 2021 as Executive Vice President and Deputy Head of Global Delivery.
• · Prior to joining State Street, she served as Global Head of Operations for BNY Mellon from February 2018 to February 2021.
• · Ms. Fogarty also served as Global Head of Fund Accounting and Administration at BNY Mellon from March 2015 to February 2018.
• · She served as Head of Hedge Fund Administration at AIB Capital Markets from January 1995 to December 2002.

14-09-2026

NPK International Inc. announced the appointment of James 'JJ' Barton as Executive Vice President, Commercial Growth & Operations, effective September 22, 2026, succeeding Lori Briggs who departs effective September 14, 2026. The filing highlights Barton's extensive experience in strategic sales, operations, and growth execution, but provides no financial metrics or performance data for period-over-period comparison.

• · James Barton holds an MBA in Corporate Entrepreneurship from Syracuse University and a B.A. in Communication and Marketing from Louisiana State University.
• · Lori Briggs served NPK for 8 years before departing.
• · Barton most recently served as President of Clear Water Services, a wholly owned subsidiary of Tidal Vision.

14-09-2026

Flowserve Corp. announced the appointment of Brian Ezzell as Senior Vice President and Chief Financial Officer, effective October 1, 2026, succeeding Amy Schwetz who is leaving for another company. The company expects no changes to its full-year guidance.

• · Brian Ezzell joined Flowserve in October 2024 as Vice President, FP&A, Treasurer, and Investor Relations.
• · Prior to Flowserve, Ezzell spent four years as Vice President, Enterprise FP&A at Kimberly-Clark Corp., with finance responsibility for the $14 billion global supply chain.
• · Ezzell is a Certified Public Accountant and began his career at PricewaterhouseCoopers.
• · The company expects no changes to its full-year guidance following the CFO transition.

14-09-2026

On September 11, 2026, Edward M. Weil, Jr. resigned from the board of directors of National Healthcare Properties, Inc., effective immediately. The resignation was not due to any disagreement with the company's operations, policies, or practices. The company filed this 8-K to disclose the departure.

• · Resignation effective September 11, 2026
• · No disagreement with company operations, policies, or practices

14-09-2026

Graco Inc. appointed Richard B. Lewis, President and CEO of Donaldson Company, to its Board of Directors, effective December 3, 2026. Mr. Lewis will serve on the Audit Committee. The appointment reflects Graco's focus on adding senior operational and commercial leadership from a public manufacturing company, with no financial terms disclosed.

• · Richard B. Lewis has been CEO of Donaldson Company since March 2026.
• · Lewis previously served as Donaldson's Chief Operating Officer and President of its Mobile Solutions and Life Sciences businesses.
• · Lewis holds a bachelor's degree in industrial engineering from the University of Louisville and an MBA from Indiana University-Purdue University Indianapolis.
• · Lewis will join Graco's Audit Committee.

14-09-2026

Rimini Street, Inc. reinstated Steven Hershkowitz as Executive Vice President and Chief Revenue Officer effective September 14, 2026, just six days after his previously reported resignation on September 8, 2026. His previous annual base salary of $480,000 and annual incentive compensation opportunity of $320,000.16 (at 100% attainment) were reinstated, and CRO responsibilities previously transferred to COO Keith Costello were reassigned back to Hershkowitz. The filing does not disclose any financial metrics or performance data, so no period-over-period comparisons are available.

• · Hershkowitz originally joined Rimini Street as EVP and CRO in April 2024.
• · Prior to Rimini Street, Hershkowitz was CRO at Virtana Corporation from February 2022 to April 2024, where he led a transition from hardware-based perpetual license to a software, subscription and SaaS model.
• · From April 2010 to February 2022, Hershkowitz held multiple roles at HPE, most recently as VP and GM of the High Performance Compute and AI organization, and previously as VP and GM of HPE's North America Large Enterprise.
• · Hershkowitz is a U.S. Air Force veteran and studied Business Administration and Management at the University of Maryland.
• · No family relationships with any executive officer or director, and no transactions requiring disclosure under Item 404(a) of Regulation S-K.

14-09-2026

Ingles Markets, Inc. filed an 8-K on September 14, 2026, disclosing the adoption of Amended and Restated Bylaws effective September 8, 2026. The amendments primarily update provisions related to capital stock (including electronic issuance and transfer of shares), shareholder meetings (including remote communication), and record-keeping procedures. The filing also covers Items 5.02 (Director/Officer Departure/Election), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 8.01 (Other Events), but no specific officer changes or financial metrics are detailed in the exhibit.

• · The Amended and Restated Bylaws were adopted effective September 8, 2026.
• · The bylaws permit the issuance of shares without physical certificates via electronic or other means, subject to applicable law.
• · Shareholders holding at least 10% of voting power may call special meetings.
• · The bylaws allow shareholder meetings to be held solely by remote communication at the Board's discretion.
• · Notice of shareholder meetings must be given 10 to 60 days in advance (20 days for mergers/consolidations).

14-09-2026

Rare Element Resources Ltd. appointed Josef Bilant as Chief Operating Officer, effective October 5, 2026. The appointment, alongside a new employment agreement detailing a US$330,000 base salary, a US$99,000 sign-on bonus, and performance-based compensation, strengthens the company's operational leadership. However, the filing solely announces an officer change and does not provide any financial results or performance metrics, so there is no data on growth or decline to report.

• · Josef Bilant, 41, holds an MBA from Temple University and a B.S. in Metallurgical Engineering from Montana Technological University.
• · No family relationships exist between Mr. Bilant and any director or executive officer of the registrant.
• · Sign-on bonus of $99,000 is subject to repayment if employment terminates voluntarily or for cause on or before October 5, 2028.
• · Long-term incentive awards may be determined by the Board, but amounts are not specified.
• · Non-compete covers rare earth activities globally and certain gold activities within a 5-mile radius of the Bear Lodge Project, unless terminated without cause.
• · The filing contains no financial results, period-over-period comparisons, or other quantitative business metrics.

14-09-2026

Sionna Therapeutics announced it will advance its dual combination SION-451 + SION-2222 into a Phase 2a proof-of-concept trial in Q1 2027, based on post hoc analyses of the failed SION-719 trial that showed a mean placebo-adjusted sweat chloride reduction of up to -8.6 mmol/L after excluding confounded participants. To prioritize the dual combination and extend cash runway into H2 2029, the company implemented a 46% workforce reduction and other cost-saving measures, expecting aggregate restructuring charges of approximately $6.4 million. While the company ended Q2 2026 with $268.3 million in cash and sees potential in the NBD1 mechanism, the prior trial failed its primary endpoint and key confounding factors were identified, tempering the positive outlook.

• · Post hoc analysis identified three confounding factors in PreciSION CF trial: PK outliers, lowered Trikafta exposures during treatment periods (mean decline of ~25-30%), and CFTR channel biology interactions.
• · Primary analysis in the trial showed placebo-adjusted sweat chloride change of -1.0 mmol/L; secondary analysis showed -1.1 mmol/L.
• · Excluding three PK outlier participants from the secondary analysis resulted in a placebo-adjusted sweat chloride change of -8.6 mmol/L.
• · Phase 1 trial of SION-451-based dual combinations achieved safety, tolerability, and PK objectives; SION-451 + SION-2222 was the preferred combination based on target exposure coverage.
• · AscenSION CF Phase 2a trial will be open-label, 28-day, enrolling adults homozygous for F508del who switch from Trikafta.
• · Cash runway extended into the second half of 2029.

14-09-2026

Firefly Neuroscience, Inc. terminated CFO Paul Krzywicki effective September 24, 2026, and appointed Jessica Paz as Chief Accounting Officer effective September 8, 2026. Ms. Paz will receive an annual base salary of $215,000 and a stock option to purchase 50,000 shares vesting over four years. The termination was not due to any disagreement with the company.

• · Ms. Paz, 46, most recently served as Senior Director of Accounting and Operations at Genvid Holdings, Inc. from April 2020 to August 2026.
• · Ms. Paz holds a Master of Science in Accounting and Finance and an MBA in Technology Management from SUNY Polytechnic Institute, and a BS in Accounting from Hunter College.
• · The Paz Indemnification Agreement provides for advancement of expenses within 20 days of written request, without regard to ultimate entitlement to indemnification.
• · The Employee Confidential Information and Inventions Assignment Agreement includes non-competition provisions during employment and non-solicitation provisions lasting one year post-employment.

14-09-2026

I-ON Digital Corp. filed an 8-K on September 14, 2026, disclosing an officer change under Item 5.02. The filing does not specify the position affected, whether it is an appointment or resignation, or the reason for the change. No financial metrics, governance details, or forward-looking statements are provided, making the disclosure minimal and largely informational.

14-09-2026

Crown Castle announced the retirement of CFO Sunit Patel (effective March 31, 2027) and the departure of COO Cathy Piche (effective September 23, 2026). Kris Hinson, currently EVP & Chief Commercial Officer, will succeed Patel as CFO on April 1, 2027. The company has initiated a search for Piche's replacement. The leadership changes follow the company's strategic shift back to a pure-play U.S. tower business after divesting its fiber and small cell operations.

• · Sunit Patel will retire effective March 31, 2027, after the filing of the 2026 Form 10-K.
• · Kris Hinson will become CFO on April 1, 2027.
• · Cathy Piche steps down as COO on September 23, 2026, and will serve as a special advisor until February 22, 2027.
• · Kris Hinson holds an MBA from Harvard Business School and an AB in Economics from Harvard College.
• · Kris Hinson previously served as VP-Corporate Finance and Treasurer, and before that spent 13 years at ExxonMobil in finance leadership roles.
• · Cathy Piche currently serves as Chair of the Wireless Infrastructure Association.

14-09-2026

Bimini Capital Management, Inc. announced that Richard Parry has joined its board of directors as a Class II director with a term expiring in 2029. Mr. Parry is President and Chief Investment Officer of Tom Johnson Investment Management, LLC (TJIM), an 80%-owned subsidiary acquired earlier this year. The appointment underscores the company's commitment to growing its asset management business following the TJIM acquisition.

• · Mr. Parry will not receive separate compensation for his board service but may be reimbursed for out-of-pocket expenses related to conferences or educational seminars.
• · Mr. Parry is not expected to serve on any board committee at this time.
• · A trust affiliated with Mr. Parry retains an equity interest in TJIM.

14-09-2026

Health Catalyst announced the appointment of Tami Reller to its board of directors, effective October 1, 2026, where she will serve as audit chair and compensation committee member. The appointment follows the naming of Simeon Kohl as CEO and President, effective September 14, 2026. The company highlights its AI-forward strategy, 18 years of results, and $2.8 billion in validated outcomes, but also discloses risks including client churn, macroeconomic challenges, and the potential underperformance of the Vitalware divestiture.

• · Tami Reller previously served as President (2021-2022), CEO (2022-2023), and Executive Chair (2023-2024) at Duly Health and Care.
• · Reller has been a board member of SPS Commerce since 2016, including five years as board chair.
• · Reller served on Avalara's board from 2014 until its acquisition, including audit and compensation committee roles.
• · Reller held senior executive roles at Microsoft and UnitedHealth Group subsidiaries, including EVP and Chief Marketing and Experience Officer at UnitedHealthcare, and CFO, CMO, and Chief Growth Officer at Optum.
• · Reller served as Treasurer of Seattle Children’s Hospital Foundation and on the board of Fairview Health Services.
• · The company's risk factors include potential client churn or down-selling related to the migration to Ignite.
• · The divestiture of Vitalware may not achieve expected benefits and could adversely affect the business.
• · Forward-looking statements are subject to risks including litigation, security incidents, macroeconomic challenges, and regulatory changes.

14-09-2026

Envirotech Vehicles, Inc. (now Azio AI Holdings, Inc.) appointed Larry G. Paige II as a Class III independent director effective September 8, 2026, filling an existing vacancy. Mr. Paige will also serve on the Audit, Compensation, and Nominating & Corporate Governance Committees. The filing does not include any financial results or period-over-period comparisons, so no quantitative performance data is available.

• · Mr. Paige's appointment is effective September 8, 2026, with a term expiring at the 2026 annual meeting.
• · He will receive a prorated portion of the annual cash retainer for non-employee directors for the remainder of 2026.
• · Mr. Paige has over 30 years of experience in military logistics, federal contracting, infrastructure, technology, energy resilience, and program execution.
• · He holds multiple advanced degrees including an M.S. in Material Logistics & Operations Research Analysis and an M.S. in Project Management.

14-09-2026

Bowhead Specialty Holdings Inc. elected Derek Walker to its Board of Directors on September 12, 2026, filling a vacancy recommended by GPC Partners Investments (SPV III) LP. Mr. Walker, a Managing Director at Gallatin Point Capital LLC, brings extensive investment and management experience and will serve as a Class II director until the 2032 annual meeting. He will not receive any cash fees or compensation for his Board service.

• · Mr. Walker was recommended by GPC Fund under the Board Nominee Agreement dated May 23, 2024.
• · Mr. Walker will stand for reelection at the 2029 annual meeting as a Class II director with term expiring at the 2032 annual meeting.
• · Mr. Walker is not eligible to receive any cash fees or other compensation for his Board service.
• · Mr. Walker holds a B.A. (magna cum laude, phi beta kappa) in Economics from Yale University and an M.B.A. (Arjay Miller Scholar) from Stanford University Graduate School of Business.

14-09-2026

Apogee Enterprises announced the election of Julie K. Streich as an independent director and her appointment to the Audit Committee, effective September 11, 2026. Ms. Streich brings extensive public-company board, financial, and operational experience, including her current role as Audit Committee Chair of Schneider National and prior service as CFO of Barnes Group. The appointment is a routine board refreshment and does not involve any financial results or material operational changes.

• · Ms. Streich served as CFO of Barnes Group from 2021 until retirement in March 2026, and as Interim CEO from March 2022 to July 2022.
• · She holds a BA in Economics and Spanish from Ripon College and an MBA in International Business from the University of Texas at San Antonio.
• · She has served on the board of Schneider National since 2023 and chairs its Audit Committee.

14-09-2026

Dexcom announced the promotion of Jereme Sylvain to Chief Operating Officer (COO), in addition to his existing role as Chief Financial Officer (CFO). Mr. Sylvain will now oversee global operations and quality teams, aiming to improve alignment and operational efficiency. The move reflects internal succession planning and a focus on scaling the business, but no financial metrics or performance data were disclosed in this filing.

• · Jereme Sylvain joined Dexcom in 2018 and has served as EVP and CFO since 2021.
• · The promotion is effective as of September 14, 2026.
• · No financial figures, revenue, or profit metrics were provided in the filing.

14-09-2026

CIMG Inc. announced the resignation of director Changzheng Ye for personal reasons, effective September 8, 2026, with no disagreement with the company. The board appointed Dongwei Li as an independent director and Audit Committee Chair, effective September 11, 2026, to fill the vacancy. Mr. Li will receive annual cash compensation of $25,000.

• · Mr. Li, 35, is Co-Founder of Zeen Tendering and Procurement (Guangdong) Co., Ltd. since January 2021.
• · From January 2015 to December 2020, Mr. Li was Director of Major Projects at Shenzhen Pagoda Industrial (Group) Corporation Limited.
• · Mr. Li holds a Bachelor of Science in Computer Science and Technology from Zhengzhou University (2009).
• · The company entered into a director offer letter and an indemnification agreement with Mr. Li, each dated September 11, 2026.

14-09-2026

Chipotle Mexican Grill has appointed Sabir Sami to its Board of Directors, effective immediately. Mr. Sami brings over 30 years of global consumer and restaurant experience, most recently as CEO of KFC. This appointment bolsters the board's international expertise as Chipotle continues to expand globally. The board now consists of 11 directors, 10 of whom are independent.

• · Mr. Sami served as CEO of KFC from January 2022 to February 2025.
• · Previously held leadership roles across KFC, Taco Bell, and Habit Burger & Grill at Yum! Brands.
• · Board size increased from 10 to 11 directors, maintaining 10 independent directors (now 91% independent).
• · Chipotle operates over 4,200 restaurants in the United States, Canada, United Kingdom, France, Germany, and the Middle East.

14-09-2026

A10 Networks expanded its Board of Directors from five to six members and appointed Mary C. Henry as a new director, effective October 5, 2026, until the 2027 Annual Meeting of Stockholders. Ms. Henry will receive standard non-employee director compensation and will enter into the company's standard indemnification agreement. No committee assignments or related-party transactions were disclosed.

• · Board size increased from five to six members
• · Appointment effective October 5, 2026
• · Ms. Henry will serve until the 2027 Annual Meeting of Stockholders
• · No committee assignments yet
• · No arrangements or understandings with other persons regarding her selection
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K
• · Compensation follows standard non-employee director arrangements per proxy statement filed March 10, 2026
• · Standard indemnification agreement per Exhibit 10.1 of Form S-1 (File No. 333-194015) filed March 10, 2014

14-09-2026

BioMarin Pharmaceutical Inc. announced the appointment of Robert Plenge, M.D., Ph.D., to its Board of Directors, effective September 10, 2026, increasing the board size from ten to eleven members. Dr. Plenge will also serve on the Science and Technology Committee and receive standard director compensation, including a restricted stock unit grant valued at $400,000. The filing contains no financial results or period-over-period comparisons, only a routine board appointment.

• · Board size increased from 10 to 11 members.
• · Dr. Plenge appointed to the Science and Technology Committee.
• · RSU grant vests on the date immediately prior to the next regular annual meeting of stockholders.
• · Company will enter into a standard indemnification agreement with Dr. Plenge.

14-09-2026

Chatham Lodging Trust appointed Liam Brown, former Marriott International group president for the U.S. and Canada, as an independent director effective immediately. Brown brings extensive lodging operations and franchisor/franchisee expertise to the board, which the chairman believes will enhance shareholder value through improved operating results and capital allocation. No financial metrics or period-over-period comparisons were provided in this filing.

• · Brown retired from Marriott in June 2026 after serving as group president, U.S. and Canada since January 2021.
• · Brown currently serves on the board of EPR Properties (NYSE: EPR) and chairs its Compensation & Human Capital Committee.
• · He also serves on the Executive Committee of the American Hotel and Lodging Association.
• · Brown holds a Hotel Diploma and Business Degree from Dublin Institute of Technology, Trinity College, and an MBA from the University of Maryland.

14-09-2026

Vista Credit Strategic Lending Corp. announced the resignation of director Stephen Riddick, effective September 14, 2026. Mr. Riddick also stepped down from the Audit Committee and Nominating and Corporate Governance Committee. The resignation was not due to any disagreement with the company, its adviser, or the board regarding operations, policies, or practices.

• · Resignation effective September 14, 2026.
• · Mr. Riddick also ceased serving on the Audit Committee and Nominating and Corporate Governance Committee.
• · No disagreement with the company, investment adviser, or board was cited as the reason for resignation.

14-09-2026

INmune Bio appointed two veteran biopharma executives, R. Duane Clark II and James Sapirstein, to its Board of Directors to bolster rare-disease commercialization and business-development capabilities as its lead candidate Ebstrocel™ advances toward potential commercialization. The appointments add commercial, market-access, and strategic transaction expertise, but the company remains in clinical development with no approved products and faces funding and regulatory risks.

• · Ebstrocel™ is being developed for recessive dystrophic epidermolysis bullosa (RDEB) and potential additional rare-disease indications.
• · CORDStrom™ platform: MAA planned for UK MHRA in 2026 and EU EMA in 2027, with a planned U.S. BLA submission.
• · XPro1595™ has FDA Fast Track designation and successful End-of-Phase 2 regulatory alignment; positioned for an integrated Phase 2b/3 seamless adaptive registrational program in neuroinflammation-enriched early Alzheimer's disease.
• · Product candidates have not been approved by FDA, UK MHRA, or any regulatory body; no assurance of approval or specific results.
• · Company faces risks including ability to produce more drug for clinical trials and need for substantial additional funding to continue operations and R&D.

14-09-2026

Inseego Corp. director Stephen Bye resigned from the board effective September 30, 2026, to become CEO of WW International. The resignation was not due to any disagreement with Inseego. No financial impact or performance data is disclosed.

• · Stephen Bye's resignation is effective September 30, 2026.
• · He is leaving to become CEO of WW International (Nasdaq: WW).
• · The resignation was not due to any disagreement with Inseego.

14-09-2026

Lesaka Technologies disclosed compensation changes for its top executives, including a salary increase for CFO Dan Smith to ZAR 7,222,500 ($447,053) and the adoption of fiscal 2027 cash incentive awards for CEO Steven Heilbron, Naeem Kola, Lincoln Mali, and Dan Smith. The incentive awards are heavily weighted toward qualitative performance criteria, such as closing the Bank Zero acquisition and driving cultural change, with maximum payouts of up to 120% of base salary. The committee retains broad discretion to reduce or eliminate awards, introducing significant uncertainty for investors.

• · The Remuneration Committee retains full discretion to reduce or eliminate cash incentive awards, including to zero, regardless of performance target achievement.
• · Heilbron's qualitative targets include closing the Bank Zero acquisition (10% weighting), transferring Consumer and Merchant lending books to Bank Zero (10% each), and completing various strategic acquisitions in fiscal 2027 (40% weighting).
• · Mali's qualitative targets include leading change in Lesaka's values system (25%), driving communication and brand management (20%), and progressing ESG initiatives (5%).
• · Smith's qualitative targets include executing finance function improvement plans (20%), integrating the Bank Zero acquisition (10%), and strengthening SOX-compliant internal controls (10%).
• · No prior-period compensation data is provided for comparison, so period-over-period changes cannot be calculated.